These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 1718683

  • 1. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D, Buckley MM, Heel RC.
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [Abstract] [Full Text] [Related]

  • 2. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
    Wilde MI, McTavish D.
    Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The clinical utility and safety of omeprazole.
    Walan A.
    Scand J Gastroenterol Suppl; 1989 Jul; 166():140-4; discussion 145. PubMed ID: 2574908
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM, Faulds D.
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ, Jarvis B.
    Drugs; 2001 Sep; 61(12):1801-33. PubMed ID: 11693467
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A.
    J Gastroenterol Hepatol; 1989 Sep; 4 Suppl 2():27-33. PubMed ID: 2491359
    [Abstract] [Full Text] [Related]

  • 11. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 12. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 13. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD, Naesdal J, Bianchi Porro G, Petrillo M, Lazzaroni M, Hinchliffe RF, Thompson M, Morris P, Daly MJ, Carroll NJ.
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [Abstract] [Full Text] [Related]

  • 14. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Apr; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 15. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
    Lundell L, Backman L, Ekström P, Enander LH, Fausa O, Lind T, Lönroth H, Sandmark S, Sandzén B, Unge P.
    Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
    [Abstract] [Full Text] [Related]

  • 16. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Apr; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 17. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD.
    Aliment Pharmacol Ther; 1993 Apr; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [Abstract] [Full Text] [Related]

  • 18. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD, Cherian P, Jones RB, Vaishnavi A, Manek S, Bishop A, Polak J, Brooks A, Morris P, Thompson M, D'Silva J, Parkin S, Patterson J, Gillon KR.
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [Abstract] [Full Text] [Related]

  • 19. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
    Maton PN.
    Aliment Pharmacol Ther; 1991 Dec; 5 Suppl 1():25-35. PubMed ID: 1679671
    [Abstract] [Full Text] [Related]

  • 20. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.